MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $227,092,200 | -35.1% | 1,555,000 | +2.6% | 3.54% | -25.4% |
Q2 2023 | $349,999,881 | -13.3% | 1,515,151 | -9.1% | 4.75% | -20.7% |
Q1 2023 | $403,766,505 | -16.2% | 1,666,666 | +0.4% | 5.99% | -16.9% |
Q4 2022 | $481,815,000 | +383.0% | 1,660,000 | +8.1% | 7.20% | +290.7% |
Q3 2022 | $99,760,000 | -9.2% | 1,535,000 | 0.0% | 1.84% | -15.1% |
Q2 2022 | $109,875,000 | -21.4% | 1,535,000 | +7.7% | 2.17% | -15.0% |
Q1 2022 | $139,821,000 | +15.8% | 1,425,000 | 0.0% | 2.55% | +24.2% |
Q4 2021 | $120,755,000 | +6.2% | 1,425,000 | 0.0% | 2.06% | +15.1% |
Q3 2021 | $113,701,000 | -18.1% | 1,425,000 | 0.0% | 1.79% | -26.0% |
Q2 2021 | $138,809,000 | -16.7% | 1,425,000 | 0.0% | 2.42% | -16.1% |
Q1 2021 | $166,682,000 | +22.4% | 1,425,000 | +16.3% | 2.88% | +22.8% |
Q4 2020 | $136,183,000 | +28.9% | 1,225,000 | +37.6% | 2.34% | +56.2% |
Q3 2020 | $105,670,000 | +166.6% | 890,000 | +154.3% | 1.50% | +91.5% |
Q2 2020 | $39,638,000 | +70.1% | 350,000 | +0.3% | 0.78% | -0.3% |
Q1 2020 | $23,299,000 | -26.7% | 349,000 | 0.0% | 0.79% | -15.8% |
Q4 2019 | $31,797,000 | +2.4% | 349,000 | -3.1% | 0.93% | -27.9% |
Q3 2019 | $31,039,000 | -17.7% | 360,000 | 0.0% | 1.30% | -0.7% |
Q2 2019 | $37,732,000 | -2.8% | 360,000 | +16.1% | 1.30% | -22.3% |
Q1 2019 | $38,831,000 | +53.1% | 310,000 | +37.8% | 1.68% | +10.8% |
Q4 2018 | $25,362,000 | -74.4% | 225,000 | -51.4% | 1.52% | -66.7% |
Q3 2018 | $99,142,000 | -27.6% | 463,000 | -5.4% | 4.55% | -13.6% |
Q2 2018 | $136,918,000 | – | 489,536 | – | 5.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |